These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 37828793

  • 1. Thrombotic microangiopathy in a patient with anti-signal recognition particle antibody-positive immune-mediated necrotizing myopathy.
    Sakai K, Takahashi M, Ito Y, Yamada S, Ito T, Higuchi Y, Kameda S.
    Int J Rheum Dis; 2024 Jan; 27(1):e14942. PubMed ID: 37828793
    [Abstract] [Full Text] [Related]

  • 2. Immune-mediated necrotizing myopathy which showed deposition of C5b-9 in the necrotic muscle fibers and was successfully treated with intensive combined therapy with high-dose glucocorticoids, tacrolimus, and intravenous immunoglobulins.
    Shimada T, Higashida-Konishi M, Akiyama M, Hama S, Izumi K, Matsubara S, Oshima H, Okano Y.
    Immunol Med; 2022 Sep; 45(3):175-179. PubMed ID: 35389818
    [Abstract] [Full Text] [Related]

  • 3. Influenza A (H3N2) infection followed by anti-signal recognition particle antibody-positive necrotizing myopathy: A case report.
    Iriki J, Yamamoto K, Senju H, Nagaoka A, Yoshida M, Iwasaki K, Ashizawa N, Hirayama T, Tashiro M, Takazono T, Imamura Y, Miyazaki T, Izumikawa K, Yanagihara K, Tsujino A, Fukuoka J, Uetani M, Satoh M, Mukae H.
    Int J Infect Dis; 2021 Feb; 103():33-36. PubMed ID: 33217572
    [Abstract] [Full Text] [Related]

  • 4. Anti-signal recognition particle positive necrotizing myopathy-sjogren's syndrome overlap syndrome: a descriptive study on clinical and myopathology features.
    Xu L, Yang MG, Hu L, Gao H, Ji S.
    BMC Musculoskelet Disord; 2023 Mar 23; 24(1):219. PubMed ID: 36959614
    [Abstract] [Full Text] [Related]

  • 5. Anti-SRP-positive necrotising myopathy concurrent with breast malignancy.
    Dandasena T, Ingle V, Singhai A, Saigal S.
    BMJ Case Rep; 2023 Dec 11; 16(12):. PubMed ID: 38081733
    [Abstract] [Full Text] [Related]

  • 6. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I, Casal-Dominguez M, Mammen AL.
    Curr Rheumatol Rep; 2018 Mar 26; 20(4):21. PubMed ID: 29582188
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
    Cui BB, Tian YR, Ma XY, Yin G, Xie Q.
    Front Immunol; 2021 Mar 26; 12():777502. PubMed ID: 34925350
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts.
    Ma X, Bu BT.
    Front Immunol; 2022 Mar 26; 13():1019972. PubMed ID: 36311711
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
    Allenbach Y, Benveniste O, Stenzel W, Boyer O.
    Nat Rev Rheumatol; 2020 Dec 26; 16(12):689-701. PubMed ID: 33093664
    [Abstract] [Full Text] [Related]

  • 13. Differences in muscle magnetic resonance imaging findings between anti-signal recognition particle antibody-positive myopathy and anti-aminoacyl-tRNA synthetase antibody-positive myositis.
    Kimura M, Aizawa A, Kudou R, Rikitake Y, Iwao C, Rikitake M, Iwao K, Kariya Y, Kawaguchi T, Matsuda M, Miyauchi S, Takajo I, Umekita K.
    Clin Exp Rheumatol; 2024 Feb 26; 42(2):321-328. PubMed ID: 37497714
    [Abstract] [Full Text] [Related]

  • 14. The pathogenesis of anti-signal recognition particle necrotizing myopathy: A Review.
    Qiu R, Wang Z, Wei X, Sui H, Jiang Z, Yu XF.
    Biomed Pharmacother; 2022 Dec 26; 156():113936. PubMed ID: 36411623
    [Abstract] [Full Text] [Related]

  • 15. [Clinical and pathological characteristics of immune mediated necrotizing myopathy].
    Yang HX, Tian XL, Jiang W, Li WL, Liu QY, Peng QL, Wang GC, Lu X.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec 18; 51(6):989-995. PubMed ID: 31848492
    [Abstract] [Full Text] [Related]

  • 16. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C, Beaufrére AM, Boyer O, Drouot L, Soubrier M, Tournadre A.
    Joint Bone Spine; 2014 Jan 18; 81(1):79-82. PubMed ID: 23953224
    [Abstract] [Full Text] [Related]

  • 17. Immune Mediated Necrotizing Myopathy: Where do we Stand?
    Mohammed AGA, Gcelu A, Moosajee F, Botha S, Kalla AA.
    Curr Rheumatol Rev; 2019 Jan 18; 15(1):23-26. PubMed ID: 29623846
    [Abstract] [Full Text] [Related]

  • 18. Rheumatoid Arthritis Associated With Anti-Signal Recognition Particle Immune-Mediated Necrotizing Myopathy: A Case Report.
    Belkhribchia MR, Lobrinus JA, Semlil L, Chauveau N, Ajrinija A, Egervari K, Ennhaili ZE.
    J Investig Med High Impact Case Rep; 2024 Jan 18; 12():23247096241231646. PubMed ID: 38353222
    [Abstract] [Full Text] [Related]

  • 19. Hypothyroidism combined with anti-signal recognition particle immune-mediated necrotizing myopathy: A case report and review of the literature.
    Shi J, Meng H, Zhang W, Guo J.
    Clin Neuropathol; 2022 Jan 18; 41(2):83-88. PubMed ID: 35034689
    [Abstract] [Full Text] [Related]

  • 20. Management of immune-mediated necrotizing myopathy.
    Suh J, Amato AA.
    Muscle Nerve; 2024 Aug 18; 70(2):166-172. PubMed ID: 38801022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.